We urge to utilize Eastwood Bio Medical analysis to find out if markets are presently mispricing the company. We were able to interpolate thirty available fundamental indicators for Eastwood Bio Medical Canada, which can be compared to its peers. The stock experiences a very speculative upward sentiment. Check odds of Eastwood Bio-Medical to be traded at C$0.7125 in 90 days. Key indicators impacting Eastwood Bio-Medical's financial strength include:
Understanding current and past Eastwood Bio-Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Eastwood Bio-Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Eastwood Bio-Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Eastwood Bio-Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Eastwood Bio Medical Canada. Check Eastwood Bio-Medical's Beneish M Score to see the likelihood of Eastwood Bio-Medical's management manipulating its earnings.
Eastwood Bio-Medical Stock Summary
Eastwood Bio-Medical competes with Covalon Technologies, Arch Biopartners, and British Amer. Eastwood Bio-Medical Canada Inc. researches and develops natural health products in North America and Asia. Eastwood Bio-Medical Canada Inc. is a subsidiary of Eastwood Bio-Medical Research Inc. EASTWOOD BIO operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.
Specialization
Consumer Defensive, Consumer Staples Distribution & Retail
You should never invest in Eastwood Bio-Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Eastwood Stock, because this is throwing your money away. Analyzing the key information contained in Eastwood Bio-Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Eastwood Bio-Medical Key Financial Ratios
There are many critical financial ratios that Eastwood Bio-Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Eastwood Bio Medical reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining Eastwood Bio-Medical's current stock value. Our valuation model uses many indicators to compare Eastwood Bio-Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eastwood Bio-Medical competition to find correlations between indicators driving Eastwood Bio-Medical's intrinsic value. More Info.
Eastwood Bio Medical Canada is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, Eastwood Bio-Medical's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Eastwood Bio-Medical's earnings, one of the primary drivers of an investment's value.
Eastwood Bio Medical Systematic Risk
Eastwood Bio-Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Eastwood Bio-Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Eastwood Bio Medical correlated with the market. If Beta is less than 0 Eastwood Bio-Medical generally moves in the opposite direction as compared to the market. If Eastwood Bio-Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Eastwood Bio Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Eastwood Bio-Medical is generally in the same direction as the market. If Beta > 1 Eastwood Bio-Medical moves generally in the same direction as, but more than the movement of the benchmark.
Eastwood Bio Medical Canada Total Assets Over Time
Eastwood Bio-Medical Thematic Clasifications
Eastwood Bio Medical Canada is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Today, most investors in Eastwood Bio-Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Eastwood Bio-Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Eastwood Bio-Medical growth as a starting point in their analysis.
Eastwood Bio-Medical November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Eastwood Bio-Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Eastwood Bio Medical Canada. We use our internally-developed statistical techniques to arrive at the intrinsic value of Eastwood Bio Medical Canada based on widely used predictive technical indicators. In general, we focus on analyzing Eastwood Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Eastwood Bio-Medical's daily price indicators and compare them against related drivers.
When running Eastwood Bio-Medical's price analysis, check to measure Eastwood Bio-Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eastwood Bio-Medical is operating at the current time. Most of Eastwood Bio-Medical's value examination focuses on studying past and present price action to predict the probability of Eastwood Bio-Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eastwood Bio-Medical's price. Additionally, you may evaluate how the addition of Eastwood Bio-Medical to your portfolios can decrease your overall portfolio volatility.